| Kelly B Dlugos, PHYSICAL THERAPIST | |
|
1900 Locust Ave Ste A, Fairmont, WV 26554-1239 | |
| (304) 333-5222 | |
| (304) 333-5224 |
| Full Name | Kelly B Dlugos |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 30 Years |
| Location | 1900 Locust Ave Ste A, Fairmont, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306888797 | NPI | - | NPPES |
| 015733000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 001311 (West Virginia) | Primary |
| 225100000X | Physical Therapist | PT017424 (Pennsylvania) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dynamic Physical Therapy Inc | 8224934708 | 5 |
| Elevate Physical Therapy Corp | 6800263955 | 4 |
News Archive
BioMarin Pharmaceutical Inc. announced today that the Food and Drug Administration (FDA) has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received orphan drug designation in the E.U.
Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema.
Bausch + Lomb, the global eye health company, and Mimetogen Pharmaceuticals Inc. today announced that Bausch + Lomb has acquired an option to license an investigational compound currently in Phase 2 development for the treatment of dry eye syndrome, a condition that affects millions of people worldwide.
Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.
The number of eggs being recalled in a multi-state Salmonella outbreak is growing.
› Verified 4 days ago
| Provider Name | Dynamic Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487647004 PECOS PAC ID: 8224934708 Enrollment ID: O20031208000662 |
News Archive
BioMarin Pharmaceutical Inc. announced today that the Food and Drug Administration (FDA) has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received orphan drug designation in the E.U.
Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema.
Bausch + Lomb, the global eye health company, and Mimetogen Pharmaceuticals Inc. today announced that Bausch + Lomb has acquired an option to license an investigational compound currently in Phase 2 development for the treatment of dry eye syndrome, a condition that affects millions of people worldwide.
Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.
The number of eggs being recalled in a multi-state Salmonella outbreak is growing.
› Verified 4 days ago
| Provider Name | Elevate Physical Therapy Corp |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1023743150 PECOS PAC ID: 6800263955 Enrollment ID: O20221103000477 |
News Archive
BioMarin Pharmaceutical Inc. announced today that the Food and Drug Administration (FDA) has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received orphan drug designation in the E.U.
Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema.
Bausch + Lomb, the global eye health company, and Mimetogen Pharmaceuticals Inc. today announced that Bausch + Lomb has acquired an option to license an investigational compound currently in Phase 2 development for the treatment of dry eye syndrome, a condition that affects millions of people worldwide.
Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.
The number of eggs being recalled in a multi-state Salmonella outbreak is growing.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly B Dlugos, PHYSICAL THERAPIST 1900 Locust Ave Ste A, Fairmont, WV 26554-1239 Ph: (304) 333-5222 | Kelly B Dlugos, PHYSICAL THERAPIST 1900 Locust Ave Ste A, Fairmont, WV 26554-1239 Ph: (304) 333-5222 |
News Archive
BioMarin Pharmaceutical Inc. announced today that the Food and Drug Administration (FDA) has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received orphan drug designation in the E.U.
Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema.
Bausch + Lomb, the global eye health company, and Mimetogen Pharmaceuticals Inc. today announced that Bausch + Lomb has acquired an option to license an investigational compound currently in Phase 2 development for the treatment of dry eye syndrome, a condition that affects millions of people worldwide.
Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.
The number of eggs being recalled in a multi-state Salmonella outbreak is growing.
› Verified 4 days ago
Jenna Snyder, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1509 Fairmont Ave, Fairmont, WV 26554 Phone: 304-363-0050 Fax: 304-363-0048 | |
Dr. David Wegert, PT, DPT, ATC Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1509 Fairmont Ave, Fairmont, WV 26554 Phone: 304-363-0050 | |
Elevate Physical Therapy, Corp. Physical Therapist Medicare: Medicare Enrolled Practice Location: 51 Middletown Rd, Fairmont, WV 26554 Phone: 304-612-5916 | |
Jeniece Marie Kegley, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1539 Country Club Rd, Fairmont, WV 26554 Phone: 843-235-9393 | |
Ms. Ila Beth Anderson, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 51 Southland Dr, Suite 2300, Fairmont, WV 26554 Phone: 304-363-3167 Fax: 304-363-1725 | |
Addison Kaufmann, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1228 Country Club Rd Ste 15, Fairmont, WV 26554 Phone: 304-366-0461 | |
Gabriel Wilson, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 719 Fairmont Ave, Suite 102, Fairmont, WV 26554 Phone: 304-363-8543 Fax: 304-363-1073 |